Inhibition of Ca(2+)-Independent Phospholipase A(2)β (iPLA(2)β) Ameliorates Islet Infiltration and Incidence of Diabetes in NOD Mice

Documenti analoghi

• β-Lactones: A Novel Class of Ca(2+)-Independent Phospholipase A(2) (Group VIA iPLA(2)) Inhibitors with Ability to Inhibit β-Cell Apoptosis
  di: Dedaki, Christina, et al.
  Pubblicazione: (2019)
• Characterization of FKGK18 as Inhibitor of Group VIA Ca(2+)-Independent Phospholipase A(2) (iPLA(2)β): Candidate Drug for Preventing Beta-Cell Apoptosis and Diabetes
  di: Ali, Tomader, et al.
  Pubblicazione: (2013)
• Evidence of Contribution of iPLA(2)β-Mediated Events During Islet β-Cell Apoptosis Due to Proinflammatory Cytokines Suggests a Role for iPLA(2)β in T1D Development
  di: Lei, Xiaoyong, et al.
  Pubblicazione: (2014)
• The Impact of the Ca(2+)-Independent Phospholipase A(2)β (iPLA(2)β) on Immune Cells
  di: White, Tayleur D., et al.
  Pubblicazione: (2021)
• Genetic modulation of islet β-cell iPLA(2)β expression provides evidence for its impact on β-cell apoptosis and autophagy
  di: Lei, Xiaoyong, et al.
  Pubblicazione: (2013)